GlassScriptPhysician profile
Stacy Eldon Mellum
NPI 1366520280
$811.56
in general payments reported to CMS, 2019-2025
17 companies · $64.79 in 2025
The $64.79 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $356 · 2020: $14.21 · 2021: $21.74 · 2022: $287 · 2023: $68.54 · 2025: $64.79.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $133.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $133.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $415.43 | 2019-2023 | |
| Astellas Pharma US INC | $77.01 | 2023-2025 | Veozah |
| Allergan, INC. | $74.30 | 2019 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.39 | 2019-2020 | |
| Coopersurgical, INC. | $24.21 | 2019 | |
| Amag Pharmaceuticals, INC. | $23.55 | 2019 | |
| Mayne Pharma Commercial LLC | $21.16 | 2023 | |
| Pfizer INC. | $20.81 | 2019 | |
| Glaxosmithkline, LLC. | $18.01 | 2019 | |
| Myovant Sciences INC. | $17.61 | 2022 | |
| Therapeuticsmd, INC. | $14.50 | 2019 | |
| Roche Diagnostics Corporation | $13.72 | 2019 | |
| Minerva Surgical, INC | $13.53 | 2025 | |
| Lupin INC. | $13.40 | 2019 | |
| Baxter Healthcare | $12.95 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $12.90 | 2019 | |
| Hologic Sales and Service, LLC | $12.08 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stacy Mellum listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.